US Moderna company vaccine 94.5 % effective against coronavirus

1

Get real time updates directly on you device, subscribe now.

US Moderna company vaccine 94.5 % effective against coronavirus

Monitoring Desk : 

The Moderna vaccine is 94.5% effective against coronavirus, according to early data released Monday by the company, making it the second vaccine in the United States to have a stunningly high success rate.

“These are obviously very exciting results,” said Dr. Anthony Fauci, the nation’s top infectious disease doctor. “It’s just as good as it gets — 94.5% is truly outstanding.” Moderna heard its results on a call Sunday afternoon with members of the Data Safety and Monitoring Board, an independent panel analyzing Moderna’s clinical trial data.
Vaccine expected to begin from the second half of December
“It was one of the greatest moments of my life and my career. It is absolutely amazing to be able to develop this vaccine and see the ability to prevent symptomatic disease with such high efficacy,” said Dr. Tal Zacks, Moderna’s chief medical officer. Vaccinations could begin in the second half of December, Fauci said. Vaccinations are expected to begin with high-risk groups and to be available for the rest of the population next spring.
Last week, Pfizer announced that early data show its vaccine is more than 90% effective against the disease.
In Moderna’s trial, 15,000 study participants were given a placebo, which is a shot of saline that has no effect. Over several months, 90 of them developed Covid-19, with 11 developing severe forms of the disease.
Another 15,000 participants were given the vaccine, and only five of them developed Covid-19. None of the five became severely ill. Information courtesy cnn.com 
US Moderna company vaccine 94.5 % effective against coronavirus

Get real time updates directly on you device, subscribe now.

You might also like